Literature DB >> 23073317

Etiologies of septic shock in a pediatric emergency department population.

Nakia N Gaines1, Binita Patel, Eric A Williams, Andrea T Cruz.   

Abstract

Knowledge of pediatric sepsis etiologies is needed to optimize empiric therapy. A retrospective cross-sectional review of 428 children with clinically diagnosed sepsis found that 13% had lobar pneumonia, 12% bacteremia and 10% viral infections. No etiologies were found in 76%. Empiric antibiotic coverage of vancomycin/piperacillin-tazobactam/gentamicin for immunocompromised children and vancomycin/nafcillin/cefotaxime for previously healthy children would have covered all bacteremic children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073317     DOI: 10.1097/INF.0b013e3182678ca9

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

1.  Etiology and prognostic factors of sepsis among children and adolescents admitted to the intensive care unit.

Authors:  Taís da Costa São Pedro; André Moreno Morcillo; Emílio Carlos Elias Baracat
Journal:  Rev Bras Ter Intensiva       Date:  2015 Jul-Sep

2.  Severe Sepsis and Septic Shock Associated with Chikungunya Virus Infection, Guadeloupe, 2014.

Authors:  Amélie Rollé; Kinda Schepers; Sylvie Cassadou; Elodie Curlier; Benjamin Madeux; Cécile Hermann-Storck; Isabelle Fabre; Isabelle Lamaury; Benoit Tressières; Guillaume Thiery; Bruno Hoen
Journal:  Emerg Infect Dis       Date:  2016-05       Impact factor: 6.883

3.  Biomarker Phenotype for Early Diagnosis and Triage of Sepsis to the Pediatric Intensive Care Unit.

Authors:  Beata Mickiewicz; Graham C Thompson; Jaime Blackwood; Craig N Jenne; Brent W Winston; Hans J Vogel; Ari R Joffe
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

Review 4.  Pediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents.

Authors:  Adrienne G Randolph; Russell J McCulloh
Journal:  Virulence       Date:  2013-11-13       Impact factor: 5.882

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.